1. Background {#sec0001}
=============

Tuberculosis (TB) is the leading cause of infectious diseases mortality worldwide, affecting 10 million people globally and killing 1.3 million in 2018 [@bib0001]. In the same year, there were an estimated 500,000 new cases of rifampicin- resistant TB (RR-TB) of which 78% were multi-drug resistant TB (MDR-TB) cases, partly a consequence of the mismanagement of TB [@bib0001]. The End TB Strategy has an objective of providing TB patients with high-quality care, in which a patient\'s human rights are central to the design and delivery of TB services [@bib0002].

Although patient-centered care is the focus of the End TB strategy, poor quality care is widespread across many low- and middle-income countries (LMICs) \[[@bib0003], [@bib0004], [@bib0005]\]. Several studies have assessed the quality of TB care in different settings and the resulting impact on patients. In India and South Africa there have been large losses to follow-up of patients at different points of the cascade of care, where 50% of patients are diagnosed and treated adequately. This was evaluated for latent TB infection (LTBI) globally where 20% of patients were diagnosed and treated adequately \[[@bib0006], [@bib0007], [@bib0008]\]. Healthcare providers are only correctly managing 21--50% of TB patients, and patients often visit multiple providers before receiving a correct diagnosis \[[@bib0009], [@bib0010], [@bib0011], [@bib0012]\]. Furthermore, once patients in LMICs enter the health system, they are faced with long diagnostic delays and often have trouble accessing adequate treatment \[[@bib0013],[@bib0014]\]. For TB patients, this can lead to devastating outcomes. Poor quality care has led to an estimated 469,956 amenable TB deaths in 2016 [@bib0015].

The recently published Lancet Global Health Commission on High Quality Health Systems in the SDG Era has acknowledged the need to improve quality of care in LMICs and has recommended that health systems be measured according to elements of competent care and user experience [@bib0005]. Improving user experience in health care is crucial to improve retention in care, adherence to treatment and public trust in the health system. The Lancet Global Health Commission defined a positive user experience as being treated with dignity and respect, having a health provider who communicates clearly, provides autonomy and confidentiality and avoids discriminatory behaviours [@bib0005]. Health services should also be easy to navigate, with short wait times and be attentive to people\'s values and preferences. This can also be defined as patient centered care. TB being a disease that is stigmatized and primarily effects vulnerable social groups, emphasizes the importance of patient-centered care [@bib0016]. Previous studies have highlighted complex pathways to diagnosis \[[@bib0017],[@bib0018]\] and high healthcare costs for patients [@bib0019], but little is known about the user experience and satisfaction with the health system. To our knowledge, there has been no systematic review of the literature examining TB user experience or satisfaction within the health system. The themes identified in this review can serve as a first step in understanding the reasons for poor quality user experience in TB care.

2. Methods {#sec0002}
==========

Our study aims to systematically review the current quantitative literature on user experience and satisfaction within the health system, synthesize current evidence, and identify further areas of research.

The protocol for this exploratory systematic review was registered on PROSPERO (CRD42018091504). The systematic review was classified as exploratory as the studies were expected to have varying exposure and outcome definitions. Hence, a broad definition of user experience and patient satisfaction were used for this review. In this study, user experience was defined as a patient\'s experience in the health system [@bib0020]. Patient could be a presumptive TB patient, asymptomatic patient and/or a confirmed TB patient. Patient satisfaction was defined as a patient\'s evaluation of the services offered within the health system, relative to their expectations of care [@bib0020]. Finally, the health system was defined as services received from both formal and informal healthcare providers.

2.1. Search strategy {#sec0003}
--------------------

Using a broad search strategy, five medical databases were searched; PubMed, Embase, Ovid Global Health, CINAHL, and Web of Science. The initial search strategy for PubMed was approved and verified by a medical librarian at McGill University (see [Appendix A](#sec0017){ref-type="sec"}). An initial search was conducted on October 24th, 2017 and an updated search was conducted in April 2019. The search included all articles from January 1st, 2009 to December 31st, 2018. No language or geographic restrictions were applied.

2.2. Study selection {#sec0004}
--------------------

Two independent reviewers conducted the title/abstract and full text screening of all articles ([Fig. 1](#fig0001){ref-type="fig"}). Articles were assessed using pre-defined inclusion criteria, and any conflicts were resolved by a third independent reviewer. The following studies were eligible for inclusion; (1) quantitative study design (2) studies with full text articles in English, (3) studies assessing user experiences with standard of TB care within the health system, (4) studies assessing user experiences from the patient\'s perspective (first person), (5) studies involving all types of TB patients and presumptive TB patients (including latent TB infection), and (6) studies conducted amongst adults (\>15 years old). Studies were excluded if: (1) qualitative study design, (2) conducted in high-income countries (as defined by the World Bank), (3) assessed user experience outside the health system (including accessibility to health care facilities) (4) evaluated costs of health care, (5) assessed user experience or satisfaction through a third person perspective (i.e. from health care worker perspective), (6) in the grey literature, (7) involved services provided outside of the health system\'s standard of care (e.g. prisons, interventions), (8) studies assessing user experiences outside the standard of TB care (i.e. quasi-experimental studies, RCTs) and (9) studies where no full text could be found were excluded.Fig. 1PRISMA diagram on study selection.Fig. 1

2.3. Data extraction {#sec0005}
--------------------

A data extraction form was created and piloted. It aimed to collect information on study characteristics, themes of user experience and patient satisfaction, frequencies and associations to outcomes (i.e. treatment outcomes, treatment delay and treatment adherence). Data was extracted by two independent reviewers using Excel. All discrepancies were resolved by consensus between the two reviewers.

2.4. Quality assessment {#sec0006}
-----------------------

A quality assessment was conducted for all studies, however studies were not prioritized and/or excluded due to their quality. The Cochrane and National Heart, Lung, and Blood Institute (NHLBI) Quality Assessment Tools for Observational Cohort, Cross-Sectional Studies, and Case-control studies [@bib0021] were used. The main elements of quality assessed were selection bias, information bias, measurement bias, and confounding. All discrepancies between quality assessments were discussed among the two independent reviewers and resolved.

2.5. Data analysis {#sec0007}
------------------

Studies used a wide number of measures that reflected components of user experience and satisfaction. Hence an inductive approach, informed by qualitative methodology, was applied to identify key themes relating to the review question. Measures of patient satisfaction from a random sample of 5 (14%) articles were accordingly first coded independently by two reviewers, after which consensus on 3 key themes was reached through full team consultation. Each study was then reviewed for reporting on one or more of these 3 themes (see [Table 1](#tbl0001){ref-type="table"}).Table 1Study characteristics and themes of TB patient experience (*n* = 35).Table 1AuthorYearCountryStudy designSample sizeHealth care sectorDisease typeData collection methodsData collection tool usedGender distributionAge distribution (mean, SD)Themes identifiedMaleFemale*N*%*N*%MeanSDPatient provider relationshipFacility infrastructure and patient-centerednessOverall satisfaction**Ali and Prins**2016SudanCase control315PublicPTB/EPTBMedical records and interviewsNR20565.111034.933.714.7YesYesYes**Adane et al.**2013EthiopiaCross sectional280PublicPTB/EPTBSelf administered questionnaireSelf made, not validated15756.112343.932.914.8YesYesNo**Babikako et al.**2011UgandaCross sectional133Public/privatePTBIndividual interviewsAdapted the PS-13 and SIMS scales6750.46649.633.610.55YesYesYes**Brunello et al.**2009BrazilCross sectional100PublicNRIndividual interviewsSelf-made, not validated6969.03131.0YesNoYes**Burapat et al.**2009ThailandCross sectional756PublicPTB/EPTBIndividual interviewsSelf-made, not validated52869.822830.234NRYesYesNo**Charles et al.**2010IndiaCross sectional606Public/privatePresumptive TBIndividual interviewsSelf-made, not validatedNRNRNRNRNRNRYesYesYes**Chimbindi et al.**2014South AfricaCross sectional296PublicIndividual interviewsSelf-made, validated14047.315652.738YesYesYes**Culqui et al.**2012PeruCase Control870PublicPulmonary TBIndividual interviewsQuestionnaire adapted from Lalone Laframboise model[a](#tb1fn1){ref-type="table-fn"}52260.034840.0NRYesNoNo**Elbireer et al.**2011UgandaCase Control344PublicNRIndividual interviewsSelf-made, not validated17651.216848.8368YesYesNo**Finlay et al.**2012South AfricaCase Control1164PublicPTB/EPTBSelf administered questionnaireSelf-made, adapted from previous study1008.6106491.4NRNRYesYesNo**Hla et al. \[**[@bib0050]**\]**2009MyanmarCase Control400PublicNRSelf administered questionnaireSelf-made, validatedNRNRNRNRNRNRYesYesNo**Lafaiete et al.**2011BrazilCross sectional88PublicNRSelf administered questionnaireValidated and adapted from Villa and Ruffino-Netto[b](#tb1fn2){ref-type="table-fn"}NRNRNRNRNRNRYesYesNo**Mehra et al.**2013IndiaCross sectional555PublicPTBNRNR37968.317631.7NRNRYesNoYes**Ndwiga et al. \[**[@bib0051]**\]**2016KenyaCross sectional140PublicNRSelf administered questionnaireNR8661.45438.635NRYesNoNo**Nezenga et al.**2013EthiopiaCross sectional531PublicNRSelf administered questionnaireAdapted from Birhanu et al. 2010 and Grant Marshall and Ron Hays (1994)[c](#tb1fn3){ref-type="table-fn"}29154.824045.2NRNRYesYesYes**Onyeonoro et al.**2015NigeriaCross sectional258Public/privateNRIndividual interviewsAdapted from used by Nwabueze et al. (2010) (PS-38)[d](#tb1fn4){ref-type="table-fn"}13953.911946.13412.8YesYesYes**Pinto & Udwadia**2010IndiaCross sectional200PrivateTBIndividual interviewsNRNRNRNRNRNRNRYesYesYes**Portela et al.**2014BrazilCross sectional4345PublicNRIndividual interviewsAdapted from Babikako et al. (2011)250757.7183842.340.9NRYesYesYes**Rankosha and Ehlers \[**[@bib0052]**\]**2016BotswanaCross sectional101NRPTB/EPTBIndividual interviewsNR5655.44544.6NRNRYesNoYes**Rashmi and Vijaykumar**2010IndiaCross sectional30PublicNRIndividual interviewsModule 6, Agha Khan foundationNRNRNRNRNRNRNoYesYes**Rutherford et al.**2013IndonediaCohort265PublicPTB/EPTBIndividual interviewsSelf-made, validated11944.914655.1NRNRYesYesYes**Salame et al. \[**[@bib0053]**\]**2017BrazilCross sectional236PublicLTBIIndividual interviewsAdapted from Rutherford et al. (2013)[e](#tb1fn5){ref-type="table-fn"}NRNRNRNR40NRYesYesYes**Satti and Nagaraj**2016IndiaCase Control240PublicPTB/EPTBIndividual interviewsSelf-made, validated14460.09640.036.59YesYesNo**Shalini and Harsh**2014IndiaCross sectional220PublicTBIndividual interviewsNR16072.76027.3NRNRYesYesYes**Slama et al. \[**[@bib0054]**\]**2013MoroccoCase Control320PublicPTB/EPTBIndividual interviewsSelf made, validated25880.66219.433NRYesNoNo**Ssengooba et al.**2016UgandaCross sectional178PublicMDR-TBSelf administered questionnaireNR7642.710257.3NRNRYesYesYes**Sulaiman et al.**2013SudanCross sectional107PublicPTBIndividual interviewsSelf made, adapted from NTP questionnaire7671.03129.041NRYesYesYes**Tamhane et al. \[**[@bib0055]**\]**2012IndiaCross sectional126Public/privatePTBIndividual interviewsSelf made, validated7559.55140.5NRNRNoYesNo**Xu et al.**2017ChinaCase Control1425NRMDR-TBOther\*NR102571.940028.144.514.8NoYesNo**Megene et al. \[**[@bib0056]**\]**2016EthiopiaCross sectional251PublicNRIndividual interviewsSelf made, adapted from Hill et al. (2005)[f](#tb1fn6){ref-type="table-fn"}11947.413252.64013.7YesYesYes**Ruru et al. \[**[@bib0057]**\]**2018IndonesiaCase Control264PublicNRIndividual interviewsNR15558.710941.3NRNRNoYesNo**Saqib et al.**2018PakistanCross sectional269Public/privatePTBIndividual interviewsNR13951.713048.3NRNRYesYesYes**Stosic et al. \[**[@bib0058]**\]**2018SerbiaCase Control124NRMDR-TBIndividual interviewsHealth survey in Serbia for 2013 and European Health Survey 2nd wave8467.74032.3NRNRYesNoNo**Yin et al. \[**[@bib0059]**\]**2018ChinaCross sectional1342NRNRSelf administered questionnaireTB related stigma scale by Yang (2016) [g](#tb1fn7){ref-type="table-fn"}90567.443732.647.7217.06YesNoNo**Htun et al. \[**[@bib0060]**\]**2018MyanmarCross sectional210PublicMDR-TBIndividual interviewsGuidelines of management of MDR-TB, Myanmar (2013)13162.47937.64115.02NoYesNo[^2][^3][^4][^5][^6][^7][^8]

Studies were categorized based on theme (e.g. patient provider relationship) and were analyzed based on frequency of themes identified, using Excel. Subsequently, descriptive statistics such as mean, median and frequencies were reported for themes of TB patient experience and patient satisfaction. Associations between aspects of user experience and treatment outcomes, delay or adherence (odds ratios, risk ratios and/or hazards ratios) were also reported.

Study variables, and exposure and outcome measures varied largely thus pooling and meta-analyses were not conducted.

3. Results {#sec0008}
==========

As shown in [Fig. 1](#fig0001){ref-type="fig"}, 35 quantitative studies were eligible for inclusion in our systematic review. Studies assessed user experience in TB care by evaluating the patient\'s perspective on the health care facilities, the providers, or by assessing overall satisfaction. [Table 1](#tbl0001){ref-type="table"} shows the main study characteristics and themes identified for each study. Studies were conducted in 16 LMICs namely; Botswana, Brazil, China, Ethiopia, India, Indonesia, Kenya, Morocco, Myanmar, Nigeria, Pakistan, Peru, Serbia, South Africa, Sudan, and Uganda.

3.1. Quality assessment {#sec0009}
-----------------------

[Figs. 2](#fig0002){ref-type="fig"} and [3](#fig0003){ref-type="fig"} represent the quality assessment for cross sectional, cohort and case-control studies (*n* = 35). Most studies (22, 63%) did not report sample size and power calculations. Among cross-sectional and cohort studies (*n* = 25), 18 (72%) either did not report or did not have a participation rate of over 50% which could have led to selection bias. In the cohort study, the exposure was measured only once over time. All case control studies, and the cohort study did not blind or did not report on whether the assessors of exposure (i.e. patient experience) were blinded to the patient\'s case or control status (*n* = 10). Further, there was large variability in tools used for measuring user experience and patient satisfaction ([Table 1](#tbl0001){ref-type="table"}). Ten (29%) studies adapted pre-existing tools; of which two (20%) were based on each other \[[@bib0022],[@bib0023]\]. Five (14%) tools were developed by the authors of the studies but were not validated before use, while six (17%) studies developed and validated their tools. One (3%) study used a pre-validated stigma scale. Eight (23%) did not report the details of their tool.Fig. 2Quality assessment of included case-control studies (*n* = 10)\*green = yes, yellow = not reported, red = no, gray = not applicable.Fig. 2Fig. 3Quality assessment of included cohort and cross sectional studies (*n* = 25)^1^This study was a cohort study. Green = yes, yellow = not reported, red = no, gray = not applicable; LTFU: loss to follow up.Fig. 3

### 3.1.1. Facility infrastructure and patient-centeredness {#sec0010}

Twenty-three studies (23/35, 66%) identified characteristics and patient-centeredness of the facilities as a theme influencing patient\'s experience with TB care. The theme of facility patient-centeredness was divided into four subthemes: wait times, ease of use, availability of equipment/supplies, and cleanliness. Six (6/23, 26%) studies evaluated overall satisfaction with facilities. For example, a study in Nigeria used a five-point Likert scale to evaluate patient satisfaction scores with different aspects of patient care. 'Amenities' was given an overall average satisfaction score of 3.27/5.00 \[0.49\] by patients, which was one of the least satisfying areas of care [@bib0024]. A study from Pakistan found that the lack of gender specific facilities in the health centers contributed to patient delay [@bib0025]. Five studies (5/23, 22%) reported that the cleanliness of the facility affected patient satisfaction. Cleanliness referred to comfort and proper hygiene.

Fifteen studies (15/23, 65%) examined how a patient\'s wait time contributed to their experience. Seven studies (7/15, 47%) measured satisfaction with wait times. Responses varied among studies, where studies in Uganda, South Africa and India \[[@bib0026]--[@bib0028]\] reported that long wait times contributed to low satisfaction with services but studies in Brazil, Ethiopia and India reported that patients were satisfied with wait times \[[@bib0023],[@bib0029]--[@bib0031]\]. Five studies (5/15, 33%) reported associations of wait times with loss to follow up (LTFU). For example, one study reported that patients were more likely to be LTFU if wait times exceeded 2 h (OR = 4.2, CI 2.18--8.02) [@bib0032]. Certain studies observed that inconvenient clinic hours resulted in LTFU. A study in South Africa described that TB patients enrolled in public health facilities were more likely to be LTFU during treatment when clinic hours were inconvenient (OR: 3.4, CI 2.2--5.2) [@bib0033]. In Indonesia, being unable to collect TB medication from a community lung clinic was significantly associated with patient LTFU (HR 22.00, CI 3.88--124.78) [@bib0034].

Eight (8/23, 35%) studies highlighted that the medical equipment or supplies in a facility affected patient experience. Two studies, in Thailand and India, reported that availability and quality of drugs influenced their choice of provider and sector \[[@bib0027],[@bib0035]\]. Further, two studies observed that the absence of drugs and supplies such as syringes, needles, and microscopes in public facilities led to non-adherence to treatment and dissatisfaction, respectively \[[@bib0030],[@bib0036]\]. In contrast, another study in Ethiopia demonstrates that 278 (99%) of patients in public facilities reported that drugs were always available [@bib0037].

### 3.1.2. Patient-provider relationship {#sec0011}

Twenty-two (22/35, 63%) studies reported patient-provider relationship as a theme affecting a patient\'s experience in the health system. The subthemes identified were confidentiality, technical capacity of healthcare workers (i.e. ability to provide diagnosis, treatment and counselling), responsiveness, health education and stigma. Most studies (14/22, 63%) reported overall positive experiences with healthcare providers, and seven (7/22, 32%) reported overall negative experiences. For example, a study conducted in Brazil among patients in the public sector observed that the highest rates of satisfaction (\>89%) were due to doctor availability during consultation and privacy during attendance [@bib0023]. However, a study conducted in South Africa among patients visiting the public sector observed that 267 (44%) patients were dissatisfied with the provider [@bib0038]. Factors influencing their dissatisfaction were: indifference by healthcare providers, delay and non-availability of healthcare providers. A study in Indonesia observed that patients who were not satisfied with their provider were more likely to be LTFU (Hazard Ratio (HR): 2.58, 95%CI: 0.99--6.75) [@bib0034].

Seven studies (7/22, 32%) reported that staff and/or health professional attitudes affected patients' experiences. A study in Sudan reported that 96% of patients found providers to be receptive [@bib0039]. However, a study in India reported 20 (9%) of DOTS patients felt that the staff was rude [@bib0040]. A Ugandan study reported that bad or fair staff conduct was significantly associated with treatment LTFU (OR 2.7, 95% CI: 1.02--7.25) [@bib0032]. Six studies (6/22, 27%) observed provider responsiveness as one of the factors influencing patient-provider relationships. Responsiveness included availability to listen, recording of patients' complaints, referrals from the provider, talking about the disease, and clarification of patients' doubts. A study in Brazil among patients in the public sector found that 56 (64%) of patients felt that reception of providers was good. Further, 53 (60%) of patients felt that providers had good availability and 55 (62.5%) of patients thought there was good guidance from the health team [@bib0031]. A study conducted in Uganda found that not being given the chance to express concerns about TB treatment was significantly associated with patient LTFU (OR: 3.5, 95% CI: 1.67--7.21) [@bib0032].

Three studies (3/22, 14%) observed that the capacity to keep information confidential and the technical capacity of providers were factors influencing a patient\'s experience. A study conducted in India identified that confidentiality was the most influential factor in choosing a medical provider for patients (468, 62%) [@bib0035]. A study conducted in Peru observed that 175 (67%) of patients felt discomfort during their treatment, due to having a bad relationship with the health worker and doubting their technical capability [@bib0041]. Six (6/35, 17%) studies identified information and health education as factors affecting a patient\'s experience in the health system. A study in Uganda in the public sector identified a significant association between not receiving adequate health education during treatment and the treatment discontinuation (OR 5.3 \[95% CI: 1.94--14.57\]) [@bib0032]. A study conducted in Morocco among TB patients in the public sector found that the perception of a patient having little or no explanation about the disease was significantly associated to LTFU (aOR 2.87, 95%CI 1.53--5.36).

Stigma was observed amongst HIV/TB or multi-drug resistant TB (MDR-TB) patients in eight studies (8/35, 23%). A study in India observed that those working at DOTS centers discriminated against HIV-TB co-infected patients more than other TB patients (aOR: 7.38; 95% CI: 2.32--23.39) [@bib0042] . A similar result was found with MDR TB patients, compared to drug sensitive TB patients (OR = 3.32; 95% CI = 1.40--7.86). Five studies (5/8, 63%) evaluated the association between stigma in the health system and TB patient treatment outcomes. A study in South Africa noted that feeling ashamed of having TB was associated with LTFU from treatment (aOR 2.0, CI 1.3--3.0) [@bib0033].

### 3.1.3. Overall patient satisfaction {#sec0012}

Nineteen studies (19/35, 54%) measured the level of patient satisfaction with TB services in the health system overall without investigation of the specific aspect of the experience that influenced satisfaction. The tools to measure satisfaction are outlined in [Table 1](#tbl0001){ref-type="table"}. Thirteen studies (13/19, 68%) measured patient satisfaction in only the public health system, while 4 (4/19, 21%) measured it in both the public and private, and 1(1/19, 5%) the private health system. Overall, studies reported that patients were either fully satisfied or satisfied with the availability and effectiveness of public TB services received \[[@bib0022],[@bib0024],[@bib0025],[@bib0034],[@bib0038],[@bib0040],[@bib0043]\]. For example, a study in Uganda measured patient satisfaction scores (maximum of 100) of the technical quality of care and management of a public and a private hospital [@bib0022]. The technical quality satisfaction score was 49.2 \[4.7\] for public health care and 96.6 \[9.5\] for private health care and were significantly different (p-value \< 0.001). Management, defined as overall satisfaction with patient care and hospital services in general, was scored at 91.1 \[10.9\] in the public hospital and 89.7 \[13.2\] in the private hospital, with no significant difference [@bib0022]. Five studies (5/19, 26%) reported that dissatisfaction of TB services was a reason for loss-to-follow-up (LTFU) or delaying treatment. In Indonesia, poor satisfaction of services in a community lung clinic was significantly associated with LTFU during treatment (HR = 3.85, CI 1.17--12.62) [@bib0034].

4. Discussion {#sec0013}
=============

This exploratory systematic review aimed to synthesize the quantitative published literature on user experience and patient satisfaction with TB care across LMICs. The studies found assessed TB patients' perspectives on the patient-centeredness of facilities (*n* = 23), the patient-provider relationship (*n* = 22) and overall patient satisfaction with TB services (*n* = 19). Studies reported that patients were mostly satisfied with TB care services, and those that were dissatisfied were substantially more likely to be LTFU. Within patient-centeredness of facilities, four subthemes were identified; wait times, ease of use, equipment and supplies, and cleanliness. Patient-provider relationship included six subthemes; staff and/or health professional attitudes, confidentiality, technical capacity of healthcare workers, responsiveness, health education and stigma.

Within each subtheme, negative patient experience was often reported to be associated with LTFU or treatment non-adherence. Healthcare staff and providers have the potential to improve patients' negative experiences, especially regarding increased patient health education, staff attitudes and technical capacity. Improving the technical capacity of healthcare workers and increasing the flow of information to patients can be addressed through healthcare staff trainings and medical workshops. To improve other aspects of care such as staff attitudes and stigma, encouraging the development of skills in patient counselling, cultural sensitivity and other soft skills may be required in medical trainings [@bib0016].

Although some studies reported negative patient experiences, the majority of studies reported high overall satisfaction of TB services. This is discrepant with evidence of widespread low quality of TB care (e.g. broken cascades of care and poor medical outcomes) [@bib0003]. The measures of satisfaction used in these studies may have been subject to acquiescence response bias, which tends to be more common among questionnaires comprising agree/disagree questions [@bib0044]. Further, patients from vulnerable and stigmatized populations are often less likely to express dissatisfaction with healthcare due to low expectations or fear of loss of services. For this reason, they may report a higher satisfaction for low quality care \[[@bib0005], [@bib0045]\]. These lower expectations could be from the lack of exposure to a good quality health system, and little access to information on health care [@bib0016]. It is therefore important to assess qualitative data to further understand reasons why patients are expressing high and/or low quality of TB services, as well as increase education on quality care.

Our study also shows large variability in measurement of user experiences and patient satisfaction. All studies used questionnaires to measure different aspects of care. Some studies (*n* = 10) used previously validated questionnaires, whereas others (*n* = 5) used self-created questionnaires which were not validated, and some (*n* = 6) used self-created questionnaires which were validated (i.e. piloted). Further, the questionnaires used had varying types of scales (i.e. 3-point Likert scale, vs yes/no vs 5 point-Likert scale). Since a standard measure of patient satisfaction was not used in these studies, the task of synthesizing the findings was challenging. Standardizing measurements of patient satisfaction can be beneficial, as data can be used for quality monitoring and improvement, within and across health facilities [@bib0046]. An example of an assessment tool to measure person-centered care was developed and validated in Kenya in 2017 for maternal health [@bib0047]. It contains 30 questions that cover 10 domains, several of which were similar to the themes identified in our study. They include dignity and respect, privacy and confidentiality, communication, stigma, health facility environment and trust [@bib0047]. Of the studies included in our review, data collection was not repeated at a different point in time to document changes in patient experience. A standardized tool would be valuable for monitoring interventions that address user experience or patient satisfaction, in order to assess if quality is improving over time. There is a need for a standardized approach to measure user experience and patient satisfaction within TB care, and to ensure the tool\'s validity, acceptability, feasibility and reliability [@bib0048].

When measuring patient-centered care, patients can be included in the design of these tools, to ensure that their experience is being accurately represented [@bib0020]. This can be done through focus group discussions with patients, or through cognitive and pilot testing of questionnaires with patients \[[@bib0020],[@bib0048]\]. While a tool can help to document user experience and patient satisfaction, the variability in our results represents the diversity of experiences that a TB patient can have. This can depend on the many factors listed in this review as well as the expectations of each patient [@bib0020]. To ensure that TB interventions and a quality improvement programs take into consideration the needs and expectations of patients in differing contexts, it is recommended that TB service and intervention design also directly involve patients. In the United States of America, among eight health organizations known for their successful patient-centered care, a variety of approaches to ensure patient engagement are utilized. This includes patient membership in advisory committees and quality improvement committees [@bib0049].

4.1. Limitations {#sec0014}
----------------

There were several limitations to this study. Firstly, a reference back check was not conducted, which may have resulted in missing studies. Our search strategy was comprehensive, and we purposely searched a wide array of medical databases, but despite this we may have missed certain articles (especially since we limited the study to English language papers). Secondly, studies focusing on qualitative results and using a qualitative data collection method (i.e. focus groups) were excluded. This was due to the large number of articles resulting from our search and feasibility of analysis with a small team. Thirdly, this review may be biased with studies reporting positive results. It is possible that studies with negative patient experiences were not published, or that settings with poor user experience are unlikely to conduct such studies. Lastly, accessibility and cost of TB services were excluded from this review, as there have already been reviews published on these topics. They should continue to be considered when planning quality improvement measurements and programs.

5. Conclusion {#sec0015}
=============

Overall, user experience and patient satisfaction with TB care were documented in 35 studies conducted in 16 LMICs, in this systematic review. Areas of care that are important to TB patients were identified including; the patient-centeredness of facilities and patient-provider relationships. There is large variability in patient satisfaction within these areas due to subjective definitions of satisfaction, different methods of capturing user experience, and individual expectations of care. Standardized data collection tools to measure user experience and patient satisfaction with TB care are needed in order to minimize this variability, as well as to monitor and improve on patient-centered quality of TB care. Additionally, patient involvement would be crucial in the creation of these tools in order to reliably and accurately measure their experience and also reduce the frequent loss to follow up associated to user experience. TB programs should focus on improving user experiences and encourage retention to care, in order to help achieve the targets of eliminating TB by 2035.
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Appendix A. Search strategy {#sec0017}
===========================

**PUBMED**

(tuberculosis\[mesh\] or tuberculosis\[ti\] or TB\[ti\])

AND

((patient satisfaction\[mesh\] OR patients/psychology\[mesh\] OR (patients\[mesh\] AND (qualitative research\[mesh\] OR "interviews as topic"\[mesh\] OR "community based participatory research"\[mesh\] OR narration\[mesh\])) OR ((patient\[tiab\] OR patients\[tiab\]) AND (experience\*\[tiab\] OR perception\*\[tiab\] OR perspective\*\[tiab\] OR attitude\*\[tiab\] OR qualitative\[tiab\] OR ethnograph\*\[tiab\] OR narrative\*\[tiab\] OR view\*\[tiab\] OR ((action\[tiab\] OR participatory\[tiab\]) AND research\[tiab\]) OR mixed method\*\[tiab\] OR mixed study\[tiab\] OR mixed studies\[tiab\] OR barrier\*\[tiab\] OR facilitator\*\[tiab\])) OR patient reported outcomes\[mesh\] OR patient reported\[tw\] OR patient acceptance of health care\[mesh\] OR patient acceptance\[tw\] OR patients acceptance\[tw\]) OR (patient satisfaction\[tw\] or patient rights\[mesh\]))

AND

((Delivery of health care\[mesh:noexp\] OR health system\*\[tw\] OR health services\[tw\] OR health facilities, proprietary\[mesh\] OR health services\[mesh\] OR healthcare\[tw\] OR care\[tw\] OR patient care\[mesh\] OR caring\[tw\] OR health services accessibility\[mesh\])))
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